Evidence map›Paper›PMID 23982603›Full record

ReviewBritish journal of cancer2013

Review of processing and analysis methods for DNA methylation array data.

C S Wilhelm-Benartzi, D C Koestler, M R Karagas, J M Flanagan, B C Christensen, K T Kelsey, C J Marsit, E A Houseman, R Brown

Open access · bronzeAbstract readReview
In one paragraph

Review in British journal of cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 217 citations in OpenAlex.

  1. Trial
  2. Multi-omics Data Integration.Advances in experimental medicine and biology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. The Open Pediatric Cancer Project.bioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Methods in DNA methylation array dataset analysis: A review.Computational and structural biotechnology journal · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

C S Wilhelm-BenartziEpigenetics Unit, Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Ovarian Cancer Action Research Centre, Imperial College London, 4th floor IRDB, Hammersmith Campus, Du Cane Road, London W12 0NN, UK.
D C Koestler
M R Karagas
J M Flanagan
B C Christensen
K T Kelsey
C J Marsit
E A Houseman
R Brown
Dartmouth College · USImperial College London · GBBrown University · USOregon State University · USOvarian Cancer Action · GB

Funding

NONMELANOMA SKIN CANCER IN NEW HAMPSHIRER01CA057494 · NCI · DARTMOUTH COLLEGE · PI KARAGAS, MARGARET RITA · 1993 to 2015
$10.9M
The Boston Collaborative Oral Cancer StudyR01CA078609 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KELSEY, KARL TIMOTHY · 1999 to 2010
$5.3M
Patterns of Somatic Gene Alterations in Oral CancerR01CA100679 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KELSEY, KARL TIMOTHY · 2004 to 2012
$2.6M
Epigenetics in Neurodevelopment and Mental HealthR01MH094609 · NIMH · DARTMOUTH COLLEGE · PI MARSIT, CARMEN JOSEPH · 2011 to 2015
$2.3M
The Molecular Epidemiology of Bladder CancerR01CA121147 · NCI · BROWN UNIVERSITY · PI KELSEY, KARL TIMOTHY · 2007 to 2010
$2.0M
Project 4: Determining How Arsenic Modulates Hedgehog Signaling During DevelopmenP20ES018175 · NIEHS · DARTMOUTH COLLEGE · PI KARAGAS, MARGARET RITA · 2010 to 2012
$892k
Cancer Research UK 13086Cancer Research UK 15954Cancer Research UK A6689NCI NIH HHS R01 CA057494NCI NIH HHS R01 CA078609NCI NIH HHS R01 CA100679NCI NIH HHS R01 CA121147NCI NIH HHS R01 CA57494NIEHS NIH HHS P20 ES018175NIMH NIH HHS R01 MH094609
6 · The paper itself

Abstract

The promise of epigenome-wide association studies and cancer-specific somatic DNA methylation changes in improving our understanding of cancer, coupled with the decreasing cost and increasing coverage of DNA methylation microarrays, has brought about a surge in the use of these technologies. Here, we aim to provide both a review of issues encountered in the processing and analysis of array-based DNA methylation data and a summary of the advantages of recent approaches proposed for handling those issues, focusing on approaches publicly available in open-source environments such as R and Bioconductor. We hope that the processing tools and analysis flowchart described herein will facilitate researchers to effectively use these powerful DNA methylation array-based platforms, thereby advancing our understanding of human health and disease.

Indexed as

DNA MethylationDNA, NeoplasmEpigenesis, GeneticHumansNeoplasmsOligonucleotide Array Sequence AnalysisDNA, Neoplasm

Identifiers

PMID23982603
PMCPMC3777004
OpenAlexW2085245717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.